Loading company…
ID 405104907 · FY 2018–2024 · 7 years
საქმიანობის ძირითადი მიმართულებაა მედიკამენტებით საბითუმო ვაჭრობა და მედიკამენტებთან დაკავშირებული საპრომოციო მომსახურება
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,478 | 4,794 | 9,290 | 6,915 | 5,484 | 6,531 | 6,744 | +7.1% |
| Total COGS | -2,923 | -3,229 | -7,267 | -4,921 | -3,307 | -4,544 | -3,935 | +5.1% |
| Gross Profit | 1,554 | 1,565 | 2,023 | 1,995 | 2,177 | 1,987 | 2,809 | +10.4% |
| Gross Margin | 34.7% | 32.6% | 21.8% | 28.8% | 39.7% | 30.4% | 41.7% | |
| Total Operating Expenses | -1,139 | -1,358 | -1,339 | -1,797 | -1,625 | -1,389 | -1,474 | +4.4% |
| EBITDA | 416 | 207 | 684 | 197 | 552 | 598 | 1,336 | +21.5% |
| EBITDA Margin | 9.3% | 4.3% | 7.4% | 2.9% | 10.1% | 9.1% | 19.8% | |
| Total D&A | -1 | -1 | -1 | -1 | -14 | -13 | -12 | +47.4% |
| EBIT / Operating Income | 415 | 206 | 683 | 196 | 538 | 584 | 1,324 | +21.4% |
| Total Interest Income | 0 | 0 | 0 | 0 | 0 | 2 | 0 | |
| Total Other Income | 27 | 14 | 53 | 23 | -11 | -25 | 105 | +25.1% |
| Profit Before Tax | 442 | 220 | 735 | 220 | 527 | 561 | 1,429 | +21.6% |
| Total Income Tax | -65 | -46 | -31 | -18 | -10 | -35 | -19 | -18.7% |
| Net Profit / (Loss) | 377 | 174 | 704 | 202 | 528 | 526 | 1,311 | +23.1% |
| Net Margin | 8.4% | 3.6% | 7.6% | 2.9% | 9.6% | 8.1% | 19.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).